Document Type

Patent

Patent Number

US Patent 9,295,713

Patent agency

United States Patent and Trademark Office

Publication Date

3-29-2016

Assignee

Celldex Therapeutics, Inc. (Needham, MA, US) ; University of Iowa Research Foundation (Iowa City, IA, US)

Application Number

13/233,916

Date Filed

2011-09-15

Total Pages

26 pages

Abstract

A method is disclosed for treating nephropathies involving undesired alternative pathway complement activation by administration of a complement inhibitory protein such as soluble complement receptor type I (sCR1).

Share

COinS
 

URL

https://ir.uiowa.edu/patents/660